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Abstract 
Adult onset amyotrophic lateral sclerosis (ALS) arises due to progressive and irreversible functional 
deficits to the central nervous system, specifically the loss of motor neurons.  Sporadic ALS causality 
is not well understood, but is almost certainly of multifactorial origin involving a combination of 
genetic and environmental factors.  The discovery of endemic ALS in the native Chamorro 
population of Guam during the 1950s and the co-occurrence of parkinsonism and dementia in some 
patients led to searches for an environmental toxins that could be responsible.  In the present paper, 
we report that an environmental neurotoxin enhances mutant superoxide dismutase (SOD)-induced 
spinal motor neuron death and pathology and induces motor axon abnormalities.  These results 
cumulatively confirm earlier findings that exposure to an environmental toxin is sufficient to 
produce the disease phenotype and indicate a role for gene-environment interaction in some forms 
of the disease. 
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Amyotrophic lateral sclerosis (ALS) is a progressive paralytic disorder that arises due to 
degeneration of motor neurons in the brain and spinal cord that invariably leads to respiratory 
failure and death.  About 10% of all ALS cases are familial (FALS), inherited in an autosomal 
dominant manner, and approximately 20% of FALS cases are caused by mutations in the antioxidant 
enzyme, superoxide dismutase 1 (SOD1)1. The remainder are sporadic with no known cause, but are 
suspected to be of environmental origin and hence likely neurotoxins.  In studies of SOD1G93A 
transgenic mice that model SOD1 FALS, functional deficits from vulnerable motor axon injury 
occurred early on during the presymptomatic period of disease 2-6.  Similar data have been observed 
in other lines of SOD1 ALS mice, with motor neuron injury causing significant motor unit loss 
during a presymptomatic window of time3, 6.  In spite of these and related studies of mSOD, there is 
considerable interest in identifying environmental causes for sporadic ALS (SALS) since purely 
genetic causal factors for ALS appear to account for only a small fraction of all disease cases.  As the 
causes for sporadic ALS have not been clearly identified, focus has been concentrated on the 
mechanisms of motor neuron diseases of genetic origin with the hope that findings can be applied 
to sporadic cases7, 8,but the link for translating FALS findings to sporadic ALS is controversial9-11.   
While studies that focus on putative environmental toxins are relatively few, to date those 
that seek to find the link between toxins and genetic susceptibility are rarer12.   
Studies of the ALS disease cluster among the Chamorro people of Guam shortly after World 
War II provided evidence of environmental causation13-15.  Similar to classical ALS, these Guamanian 
cases usually showed signs of upper and lower motor neuron losses developing invariably during the 
course of the illness while extraocular muscle weakness and objective sensory deficits were largely 
absent16, 17.  An atypical form of parkinsonism that presented with dementia emerged also with high 
incidence, sometimes overlapping with ALS in the same patient.  All cases showed a wide 
distribution of Alzheimer’s-like neurofibrillary tangles in the absence of senile plaques18.  Consistent 
with an environmental etiology, consumption of flour made from cycad seeds, a recognized feature 
of Chamorro culture for generations19 appeared to be involved.  Cycad seed flour was found to 
contain a variety of neurotoxins, some of which remained in the flour after washing.  Of these, we 
focussed our attention on several steryl glucosides (SG)20-23.  These molecules are neurotoxic to 
primary neuronal and astroglial cultures20 as well as to motor neuron-derived cell lines22.  Moreover, 
synthetic steryl glucosides fed to mice caused motor deficits consistent with an ALS-PDC 
phenotype, notably a progressive motor neuron loss in spinal cord and later cell loss in the 
striatum23, 24.  Motor neuron loss in animal models is demonstrable by the cycad neurotoxins linked 
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to Guamanian ALS and parkinsonism25, 26.  In vivo studies in adult CD-1 mice exhibited dramatic 
motor deficits followed by progressive cognitive dysfunction after 30 days of exposure to cycad 
flour 25.  Following 70 days of cycad feeding, quantitative magnetic resonance imaging in adult CD-1 
mice showed decreased volumes in lumbar cord grey matter, substantia nigra, striatum, motor 
cortex, and basal nuclei26.  Collectively, these studies indicated a primarily neurotoxic etiology to 
ALS-PDC.  By implication, neurotoxic etiologies might apply to other related diseases.   
Similar data has been reported for SOD1G93A mice without cycad exposure, where the 
primary difference involved decreases in spinal cord white matter volume in transgenic animals 27.  
In addition to spinal cord pathology in SOD1G93A mice, denervation of neuromuscular junctions 
was observed following followed by limited axon terminal sprouting that form new synaptic 
connections with denervated muscle fibers28, 29, 29, 30.  Studies in G93A transgenic mice have reported 
that motor axons innervating fast-twitch fatigable type IIB muscle fibers are selectively vulnerable 
and fail to sprout, while those innervating fast fatigue-resistant (type IIA) or slow (type I) fibers are 
resistant and retained their sprouting competence 3, 6.  Motor axon abnormalities in the mutant 
SOD1 mouse model appeared to occur in a retrograde degenerative fashion, with intact proximal 
axons but with neuromuscular junction denervation 2.  Still the possibility of anterograde 
degeneration in ALS cannot be completely discounted 31, and human post mortem material is almost 
always from end stage patients where it is difficult to study pathological changes in the 
neuromuscular system with any accuracy.  However, neuromuscular junction vulnerability may not 
play a key role in all forms of ALS, as noted in a mouse model of Guamanian ALS-PDC where 
lower motor neuron loss and pathology preceded denervation of the neuromuscular junction 32.   
Although the data supporting neurotoxins in ALS, including the impact of steryl glucosides 
is intriguing, it is uncertain whether these or other toxins are alone responsible for the pathological 
outcomes or whether they may work in conjunction with genetic susceptibility factors.  The idea of 
genetic and environmental interplay has been an established focus for numerous studies, and is not 
limited to neurodegenerative diseases33, 34.  Based on the above studies using cycad seed flour or the 
derived toxins, we tested the hypothesis that similar toxins could modify the onset and progression 
of disease symptoms in SOD1 transgenic mice.  To explore this hypothesis, the current study 
distinguished between the pathological consequences of either genetic predisposition to 
neurodegeneration or neurotoxin acting alone on motor axons, and the site of primary pathogenesis 
when both stressors act in combination.  
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RESULTS 
Chronic SG exposure leads to progressive motor function deficits 
Motor coordination deficits on the rotarod began appearing in wild type mice with SG 2 weeks after 
beginning SG treatment in males (Fig. 1a) and 8 weeks in females (Fig. 1b).  The effects reached 
statistical significance by 8 weeks of SG treatment in males (repeated measures ANOVA; p < 
0.0001) and 18 weeks in females (repeated measures ANOVA; p = 0.008).  While SG-fed female 
wild types showed a decline in latency to fall compared to controls, this effect started after 40 weeks 
of age and was not significant (F = 1.86, p = 0.17).  Significant main effects of SG exposure on 
performance (F = 6.58, p = 0.01) were observed in male mice only before those arising from the 
genotype alone (F = 0.84, p = 0.36).  In contrast, significant main effects of the G37R mutation 
were observed in female mice (Fig. 1b; F = 13.03, p = 0.0004).  The performance on the rotarod of 
G37R transgenic mice was almost identical to wild type littermates for both sexes during the 
baseline testing period between 4 to 10 weeks of age before commencement of SG treatment (Fig. 
1).  The combined impact of the toxin on the mutant mice was highly significant (F = 645.81, p < 
0.0001).  Similar to the male counterparts, an interaction between SG and SOD1G37R genotype was 
also observed in females (F = 1699.02, p < 0.0001).  Wild type mice without SG (controls) showed a 
similar level of rotarod performance throughout the study, as demonstrated by a minimal change in 
performance with increasing age.   
Mutant SOD1 motor neurons show morphometric alterations 
No significant differences in ChAT-positive cell counts were found in SG-fed wild types (p = 0.12 
for males, p = 0.09 for females), although the cell count was noticeably smaller in this group for 
both sexes (26% decrease compared to controls; Fig. 2).  One-way ANOVA showed no significant 
main effects of the SG diet in males (F = 2.7, DF = 34, p = 0.16) or in females (F = 1.7, DF = 40, p 
= 0.15).  In comparison with wild type controls, significant decreases in ChAT-positive cell count 
were found in G37R mice (p = 0.019 for males, p = 0.0017 for females).  Significant main effects 
were observed for genotype in both males (F = 1.2, DF = 34, p = 0.002) and females (F = 1.04, DF 
= 40, p = 0.0002).  For SG-fed G37R mice the decrease in ChAT-positive cells was more 
pronounced (p = 0.0034 for males, p = 0.0008 for females).  Analysis of gene × diet interaction 
showed no significance in males (F = 0.27, DF = 34, p = 0.61) and females (F = 0.01, DF = 1, p = 
0.91).  However, when all the animals from both sexes were combined, significant main effects of 
both diet (p = 0.007) and genotype (p < 0.0001) were found.  In contrast, no significant diet × 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.6
55
9.
1 
: P
os
te
d 
27
 O
ct
 2
01
1
genotype interaction was observed (p = 0.66).The appearances and numbers of motor neurons were 
not significantly different between the left and right ventral horns (data not shown).   
 All groups exhibited morphologically abnormal neurons that appeared to be undergoing 
degeneration among a larger population of healthy cells (Fig. 3).  The graph of motor neuron 
number showed a normal distribution of Nissl stained neuronal diameters (Kolmogorov-Smirnov 
test; p > 0.01).  The reduced proportion of large diameter motor neurons lumbar ventral horn of 
G37R and/or SG-fed groups and the consequent significant reduction in cell diameter range are 
further illustrated in the cumulative distribution functions (Fig. 4).  A significant leftward shift of the 
cumulative distribution function in SG-fed wild type (Tukey HSD post hoc test; p < 0.001), control-
fed G37R (Tukey HSD post hoc test;p = 0.001), and SG-fed G37R (Tukey HSD post hoc test;p < 
0.001) female mice indicates a decline in soma diameters of neurons with an apparently normal 
morphology (Fig. 4a).  Chromatolytic neurons also showed significant leftward shifts in the 
cumulative distribution in both the SG-fed groups (Tukey HSD post hoc test;p < 0.001, wild type SG; 
p = 0.01, G37R SG), while a leftward shift of the G37R groups was not significant (Tukey HSD post 
hoc test;p = 0.328; Fig. 4b).  No significant shifts were observed in the diameter of pyknotic neurons 
between groups (Fig. 4c).  Data for significant leftward shift revealed similar results in male mice, 
with the exception of two differences.  Significant leftward shifts in the cumulative distribution of 
healthy neurons were greater between male groups (Fig. 4d) than females, and chomatolytic neurons 
only showed leftward shifts in the cumulative distribution of in SG-fed G37R mice (Fig. 4e) 
compared to controls.  In summary, SG-fed mice showed significant leftward shifts in healthy 
neurons for males (p < 0.05) and for chromatolytic neurons in females (p < 0.05) compared to non 
SG-fed wild type mice.  Mutant mice showed significant leftward shifts towards smaller apparently 
normal neuronal diameters (males p < 0.0001; females p < 0.001) compared to wild type mice.  The 
combination of SG with the mSOD mutation gave significantly smaller cell diameters for both 
healthy and chromatolytic neurons (males p < 0.05; females p < 0.05).  Table 1 summarizes multiple 
comparisons of cumulative frequency histograms between groups, broken down by sex and cell 
morphology.   
Glia from mSOD mice exhibit non-synchronous changes to an activated 
morphology 
Astrocyte gliosis was determined by quantifying the immunohistochemical labelling intensity of 
green fluorescent GFAP positive cells in the ventral horn of the lumbar spinal cord in conjunction 
with blue Hoechst staining (Fig. 5).  Astrocyte distribution was sparse in the lumbar cord of wild 
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type controls (Fig. 5a) and SG-fed wild type mice (Fig. 5d).  Astrocytes were observed in their 
resting morphology with long, thin processes and a small cell body (Figs. 5c, f).  Treatment with SG 
in wild type mice showed a significant trend for increased GFAP labelling in both males (student’s t 
test; p < 0.0001; Fig. 5o) and females (student’s t test; p = 0.037; Fig. 5o).  G37R lumbar cords 
showed a marked increase in astrocyte gliosis for both sexes (student’s t test; p << 0.0001).  
Furthermore, control-fed G37R mouse cord showed astrocytes that were exclusively in the activated 
state with enlarged cell bodies and thickened, retracted processes (Fig. 5j, k) or astrocytes that 
exclusively showed increased branching of long thin processes (Fig. 5h, i).  Treatment with SG in 
G37R animals did not increase astrocyte proliferation further in males (student’s t test; p = 0.48), but 
significantly decreased GFAP label intensity in females (student’s t test; p = 0.017). All GFAP-
positive cells in this group were astrocytes with an activated morphology (Fig. 5m, n).   
 Significant main effects of genotype on increased GFAP green fluorescence intensity was 
observed in males (one-way ANOVA; F = 3.69, DF = 222, p << 0.0001) and females (one-way 
ANOVA; F = 2.49, DF = 221, p << 0.0001).  Interaction between diet and genotype was significant 
for both males (one-way ANOVA; p = 0.007) and females (one-way ANOVA; p = 0.001).  In 
summary, SG-fed mice showed significant increases in GFAP label intensity in the lumbar cord grey 
matter (males p < 0.0001; females p < 0.05) compared to non SG-fed wild type mice with astrocytes 
in the resting state.  Mutant mice showed even greater significant GFAP infiltration (males p < 
0.0001; females p < 0.0001) compared to wild type mice with astrocytes either exclusively in an 
altered resting morphology or an active morphology.  The combination of SG with the mSOD 
mutation did not change astrocyte numbers, but induced an active astrocyte morphology in all 
animals.   
Microglial proliferation was described by quantifying the immunohistochemical labelling 
intensity of red fluorescent Iba1 positive cells in the ventral horn of the lumbar cord in conjunction 
with blue Hoechst staining (Fig. 6).  Microglial distribution was minimal and uniform in control-fed 
(Fig. 6a, b) and SG-fed (Fig. 6d, e) wild type lumbar cord.  In both these groups, Iba1 positive cells 
were observed as ramified microglia with a small round cell body (Figs. 6c, f) and differences in 
microglial label intensity were comparable in both males (student’s t test; p = 0.35) and females 
(student’s t test;p = 0.051; Fig. 6m).  Control-fed G37R lumbar cords showed a marked increase in 
microgliosis for both sexes (student’s t test; p << 0.0001).  Iba1-positive cells in this group were 
observed to have both enlarged “amoeboid-like” cell bodies with retracted processes (Figure 6h) and 
cells with remaining processes that have not yet retracted (Figure 8i, arrow) in the same spinal cord.  
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The latter proportion of microglia appeared to be in transition between a quiescent ramified resting 
state and an activated state.  Treatment of SG in G37R animals did not increase astrocyte 
proliferation further in females (student’s t test;p = 0.28), but significantly increased Iba1 label 
intensity in males (student’s t test;p = 0.006; Fig. 6m).  Virtually all Iba1-positive cells in this group 
assumed an activated morphology with retracted processes and large cell body (Fig. 6k, l).  
 Significant main effects of genotype on increased Iba1 red fluorescence intensity was 
observed in males (one-way ANOVA; F = 3.4, DF = 220, p << 0.0001) and females (one-way 
ANOVA;F = 2.75, DF = 220, p << 0.0001).  Interaction between diet and genotype was significant 
for both males (one-way ANOVA;p = 0.008) and females (one-way ANOVA;p = 0.002).  In 
summary, SG-fed mice no changes in Iba1 label intensity in the lumbar cord grey matter (males p = 
0.35; females p = 0.51) compared to non SG-fed wild type mice with microglia in the resting state.  
Mutant mice showed significant microglial infiltration (males p << 0.0001; females p << 0.0001) 
compared to wild type mice with microglia in a transition state between resting and active 
morphology, but most with an active morphology.  The combination of SG with the mSOD 
mutation did not change microglia numbers in females (p = 0.28), but significantly increased 
microgliosis in males (p = 0.051) while an active astrocyte morphology was observed in all animals.   
SG toxicity does not contribute to motor axonopathy caused by mutant SOD1 
Evaluations of muscle end plates with rhodamine conjugated α-bungarotoxin immunofluorescence 
showed significant abnormalities in all G37R groups of both sexes (Fig. 7).  Virtually all endplates 
(>90%) were innervated in wild type mice of both sexes.  Prolonged exposure to SG in wild type 
mice did not significantly change neuromuscular junction innervation in either sex (p = 0.75 in 
males; p = 0.066 for females), as reported previously 32.  G37R mice showed significant end plate 
denervation compared with wild types, with 65% denervation in males (p = 0.0005) and 82% 
denervation in females (p < 0.0001; Figure 7d, g).  Following treatment with SG in G37R mice, 
levels of denervation did not change significantly (83% in males, p < 0.0001; 64% in females, p = 
0.0005;).  The levels of denervation between non-SG-fed and SG-fed G37R mice was not significant 
(p = 0.36 for females; p = 0.12 for males). 
The axon diameter distribution histogram showed a normal distribution of toluidine blue 
stained motor axon diameters for the controls (Kolmogorov-Smirnov test, p > 0.01) while 
distribution of axonal diameters for other groups did not show a normal distribution (Kolmogorov-
Smirnov test, p < 0.01).  The frequency distributions of axon diameters were different between wild 
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type and G37R mice (Fig. 8a).  In controls, motor axons have a wide distribution of axon diameters, 
with the greatest number of axons having a diameter between 6 and 9 μm.  SG-fed wild type mice 
showed a comparable wide distribution of axon diameters, with the greatest number of axons having 
a diameter between 6 and 10 mm.  SG-fed wild types also showed a greater number of motor axons 
<10μm in diameter than the controls.  Both G37R groups showed a similar wide distribution range, 
although skewed toward smaller axon diameters compared to wild types.   
The reduced proportion of large diameter motor axons in the lumbar ventral root of both 
G37R groups and the consequent significant reduction in axon diameter range are further illustrated 
in the cumulative distribution functions (Fig. 8b).  A significant leftward shift of the cumulative 
distribution function in SG-fed G37R (p < 0.05), control-fed G37R (p < 0.05) indicates a decline in 
axon caliber in these groups.  No significant shifts of the cumulative frequency histogram were 
observed in SG-fed wild types compared to controls (p > 0.05).  In addition to a leftward shift in the 
normal distribution for G37R groups, a steeper slope for the smallest diameters was observed for 
these groups.  This observation is consistent with the frequency distribution histogram which shows 
greater numbers of axons in the smaller diameter ranges. 
Discussion 
The results of the present study demonstrate the contribution of an identified neurotoxin linked to 
some forms of ALS to the progression of motor deficits and neurodegenerative processes of a 
mouse model of ALS.  Chronic dietary administration of this toxic steryl glucoside also induced 
significant reductions in motor function during behavioural tests as reported in previous studies 23, 32.  
These studies showed that motor coordination and grip endurance were impaired from 8 weeks of 
chronic SG exposure in males and from 18 and 38 weeks, respectively, in females.  In addition, 
hindlimb extension showed deficits by 12 weeks of SG feeding in males, and 26 weeks in females.  
There was a non-significant trend towards motor neuron loss and increased gliosis in the lumbar 
ventral horn at disease end-stage, and there was significant gene × diet interaction effect on gliosis.  
At disease end stage, when degenerative changes in motor neurons and cell death are well underway, 
marked synaptic loss in motor endplates and reduction in axon calibre occur in mutant mice.  
Chronic treatment with SG had no effect on furthering these degenerative changes in peripheral 
motor components in G37R mice.  Although in vitro studies have shown that synthetic cycad steryls 
act directly on neural cells 20, 22, SG appears to be primarily involved in inflammatory reactions and 
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motor neuron pathology in the spinal cord.  The fact that SG-mediated neuropathology was only 
noted in the spinal cord where neuronal cell death mainly occurs indicates that it could contribute to 
cell dysfunction leading to neurodegeneration in SOD1 mutant mice.  Thus, our data suggest that 
environmental toxins initiate neural pathogenesis by triggering inflammation-mediated 
neurodegeneration with an additive effect on the processes triggered by mutant SOD1.   
Our results are in agreement with our earlier behavioural 23, 25 and histological 26, 35 studies on 
the effects of chronic cycad exposure on motor impairments in mice.Data have also been reported 
for synthetic cycad toxins, where significant motor dysfunction is evident following 30 weeks of 
chronic treatment, and the onset of motor neuron death was observed from 15 weeks 23.  We have 
previously reported some parallels between the time of appearance of these pathologies and the 
progression of motor deficits in cycad-fed male mice 32.  Here, our results demonstrate declines in 
rotarod performance in G37R male mice by 30 weeks of age, the maximum age at which 
behavioural results are available for these mice, corresponding to 15 weeks of age with SG exposure.  
Earlier reports have shown late (40-50 weeks of age) declines in rotarod performance of G37R 
mice36, 37.  In contrast, preferential motor unit loss from fast-twitch muscles 4 and the initiation of the 
denervation process of motor endplates 2 start earlier, before the onset of disease symptoms in 
G93A mice.  Considering that SOD1 mice present marked deficits in the compensatory sprouting 
capacity of their motor neurons 5, it is likely that these deficits lead to the presentation of locomotor 
dysfunction. 
The results of this study showed significant leftward shifts in the cumulative histogram of 
soma diameter distribution in non-SG-fed and SG-fed G37R cords of both sexes.  Studies in G93A 
mice reported preferential loss of the most forceful motor units paralleled by denervation of large 
type IIB (fast-fatigable) muscle fibers and indicate conversion to motor units innervated by smaller 
motor axons during the presymptomatic stage 5.  Observations of a significant reduction in motor 
neuron diameter at disease end stage in this study support the possibility of activity-dependent 
conversion to smaller motor axons innervating type IIA (fatigue resistant) muscle fibers. 
Prolonged dietary exposure to SG elicited asignificant astrocytic response in the ventral 
lumbar horn of both sexes that was more pronounced in males than females (58% increase in males 
compared to 20% in females).  This finding is consistent with previous studies of toxin 
administration to male mice25, 32, and provide novel data for glial responses in females.  G37R 
expression elicited a prominent microglial and astroglial response, some of which showed 
morphological changes reminiscent of activation.  Prominent hypertrophic astrocytes and irregular 
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amoeboid shaped microglia are predominantly located in the anterior horn of symptomatic G37R 
mice 38, 39.  Enhanced gliosis as measured by increased microglial cell numbers and GFAP staining 
intensity was observed in other studies of this line of symptomatic G37R mouse 40.  Prolonged SG 
exposure in G37R mice showed similar widespread distribution of microglia and astrocytes, all of 
which became hypertrophic with retracted processes.  This is a novel finding demonstrating that SG 
targets the type of glia (resting or activated) even in the absence significant increases in gliosis, as in 
the case of the microglial response.  Although the effects of SG on eliciting a glial response are small 
compared to the genetic effects, significant diet × genotype interactions were observed in both 
sexes.  The effects of SG alone on increasing glial infiltration and motor neuron loss do not reach 
significance, although there appears to be increased gliosis and cell loss in SG-fed mice.  Hence the 
overall effect of SG is not greater in combination with SOD mutation because the effect of interest 
is saturated by the mutation alone.  Another likely explanation is the high variability of data between 
animals in the SG-treated groups.  
 Synaptic loss at motor end plates of the gastrocnemius muscle of mutant SOD1 mice was 
consistent with the remarkable decline in motor function and paralysis of the hind limbs.  Numerous 
other studiesshow early vulnerability of fast-type neuromuscular synapses and functional motor unit 
losses 3, 4, 6in SOD1 ALS models.Atkin and colleagues reported no detectable muscle pathology in 
presymptomatic SOD1 G93A mice and selective denervation of a subset of fast twitch muscle fibers 
at disease end stage 41.  Other studies detected skeletal muscle denervation in SOD1 G93A mice as 
early as 47 days 2, 42, and still other studies reported denervation occurring later at 10 weeks 42.  The 
diagnosis of neuromuscular junction pathology is not limited to denervation, and may include other 
individual features such as neurofilament accumulation, pathological involvement of terminal 
Schwann cells and/or their neighbouring neuromuscular junction capping cells, or pathology of the 
postsynaptic components of the neuromuscular junction that includes motor end plates.  Hence an 
important question is what features should be considered as essential or relevant aspects of synaptic 
pathology.     
 Another major finding demonstrated here is a significant reduction in motor axon caliber in 
G37R mice that is unaffected by chronic SG dietary administration.  The numbers of large caliber 
axons is significantly lower in G37R ventral roots compared with wild types, while the number of 
small caliber axons is increased.  This finding is consistent with increased numbers of small axon 
fibers and greater frequency of axonal degeneration in the ventral spinal root of ALS patients 43.  
Other studies in the same line of G37R mice reported significant reductions in axonal proteins 
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before disease onset and massive axonal loss in L5 ventral roots at disease end stage 39, 40, 44.  Large 
myelinatedfibers undergo atrophy, while myelin sheaths increase in thickness and show various 
irregularities 45.  The degree of demyelination (or abnormalities in myelination) has not been 
described in this G37R mouse line, but it is possible that mutant SOD1 triggers an advanced aging 
process on the large fibers of spinal motor neurons. A marked increase in small caliber axons at 
disease end stage may indicate new growth rather than persistent axons, occurring in the form of 
thin branches that emanate primarily from axons as opposed to terminal sprouts.  Motor neurons 
innervating type I and type IIA muscle fibers retain sprouting competence compared to the loss of 
sprouting competence in motor neurons innervating the fast-type-fatigable type IIB fibers3, 6.  
However, in the present study it was impossible to distinguish between thin axons that are refractory 
to degeneration from new (reinnervating) thin axons that are compensatory.  Alternatively, the 
identity of these small caliber axons may be gamma efferentfibers which innervate the intrafusal 
muscle fibers.     
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 Table 1.  Significant differences in cumulative frequency of cell diameter 
  Group A Group B Mean Difference (A-B) Std. Error Sig. 
Female Healthy WT control WT SG 1.90404‡ 0.33439 0.000 
G37R control† 2.38695‡ 0.40984 0.000 
G37R SG† 3.14666‡ 0.83560 0.001 
G37R control G37R SG 0.75971 0.87442 0.821 
Chromatolytic 
 
WT control 
 
WT SG† 3.86972‡ 0.85381 0.000 
G37R control 1.36135 0.80405 0.328 
G37R SG† 7.51196 ‡ 2.40517 0.010 
G37R control G37R SG 6.15062 2.44841 0.059 
Shrunken WT control WT SG 0.91126 1.03601 0.815 
G37R control 1.23046 1.16837 0.718 
G37R SG 2.95917 2.05953 0.478 
G37R control G37R SG 1.72871 2.20323 0.861 
Male Healthy WT control WT SG† 3.53183‡ 0.43672 0.000 
G37R control† 6.40946‡ 0.64949 0.000 
G37R SG† 6.83329‡ 0.63974 0.000 
G37R control G37R SG 0.42383 0.80981 0.953 
Chromatolytic 
 
WT control 
 
WT SG 2.62669 1.20977 0.133 
G37R control -0.32220 0.95462 0.987 
G37R SG† 5.55371‡ 1.88347 0.018 
G37R control G37R SG 5.87590‡ 1.83170 0.008 
Shrunken WT control WT SG 1.26020 1.01737 0.603 
G37R control 2.74375 1.74477 0.397 
G37R SG 1.08518 2.34086 0.967 
G37R control G37R SG -1.65857 2.70299 .928 
† Indicates groups that were found to show significant leftward shift compared to WT controls.   
‡Denotes significant mean difference at the 5% level.  Data expressed as multiple comparison using 
Tukey HSD post hoc test. 
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Methods 
Animals.A colony of mice heterozygous for the G37R mutation (line 29) of the human gene for 
SOD1, were obtained from the laboratory of Dr. Neil Cashman (Vancouver, BC, Canada).  The 
original breeder mice were produced by Dr. D.W. Cleveland by microinjecting a plasmid encoding 
wild type human SOD1 contained within 12 kb genomic DNA fragment into hybrid (C57BL/6J x 
C3H/HeJ) F2 mouse embryos.  The G37R mutation was introduced into the human SOD1 gene by 
PCR using a mutagenic primer.  Transgenic mice from this founder line (line 29) express a (7-fold) 
increase in SOD1 activity in spinal cord, with pathology restricted to motor neurons in the spinal 
cord and brainstem46.  The laboratory of Dr. Cashman maintained the transgene by breeding male 
hemizygotes to naive C57BL/6 dams, and continued until all progeny were on a pure C57BL/6 
background.  In this study, C57BL/6 +/+ female mice were paired with C57BL/6 SOD1G37R/+ 
male hemizygous carriers and the progeny from the breeding were ear punched for genotyping at 
Transnetyx, Inc (Cordova, TN, USA).  Non-transgenic littermates were used as controls.  Animals 
were weaned at 3 weeks of age and housed individually at Jack Bell Research Centre (Vancouver, 
BC, Canada) at a constant temperature of 21 – 22oC and a 12-hour light/dark cycle.  All procedures 
such as animal husbandry, treatment, and euthanasia were carried out in accordance with the 
regulations and guidelines of the Canadian Council on Animal Care and National Institute of Health 
and approved UBC Animal Care protocols.  For analysis of disease progression in a toxic-induced 
nervous system, transgenic animals and non-transgenic littermates at 10 weeks of age were started 
on a daily diet containing 42 mg of sterylglucoside (SG) per kilogram of body weight.  The 10 week 
starting point for SG feeding allowed time for sufficient baseline motor behavioural testing after 
weaning at 3 weeks.  The 42 mg/kg body weight dose of SG corresponds approximately to those 
reported in Tabata et al 23.  However, in the previous study, toxin exposure was set at a fixed 
concentration and began at 5 months of age.  The weight adjustment in the current study was 
administered to ensure a consistent dosage corresponding to the size of the animal at specific ages, 
since animals in this study were followed up to 13 months of age.  It is important to note that the 
pellet containing sterylglucoside was only a part of the overall diet, with the other part consisiting of 
regular mouse chow.  In the comparative study, age-matched transgenic animals and wild type 
littermates not receiving sterylglucoside but rather a placebo flour pellet were used.  These control 
animals were maintained on a regular mouse chow diet of daily proportions equal in weight (and 
caloric value) to the diet containing toxin.  Mice were considered at end stage of the disease when 
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they were severely paralyzed and were unable to right themselves within 30 seconds when placed on 
their side. 
Behavioural assessment.Animals were observed daily for development of tremor, weakness, and 
loss of weight.  At regular 3 week intervals, starting at 4 weeks of age when no signs of disease 
symptoms were present and up to 51 weeks of age, animals were monitored for onset of disease 
phenotype.Motor performance was monitored by Rotarod testing using an IITC Rotarod (IITC Life 
Science Inc., Woodland Hills, CA; #755).  Mice were placed on a partitioned rotating rod 1.25 inch 
in diameter and tested at a constant speed of 30 RPM.  Animals fell onto a platform that is sensed 
by magnetic switches and the time that the animal remains on the rod (up to a maximum of 180 
seconds) is displayed and recorded.  Rotarod testing was performed on the same day as grip 
endurance testing. 
Immunocytochemistry and cell labeling.For immunocytochemistry and other cell labeling, we 
processed CNS tissue as we previously described 32.  Primary antibodies were goat polyclonal 
antibodies to ChAT (1:100; Millipore); rabbit polyclonal antibody to Iba1 (1:200; Wako Chemicals), 
mouse monoclonals to GFAP (1:100; Cell Signalling) and NF160 (1:200; Millipore); Alexa594-
conjugated α-bungarotoxin (1:200, Invitrogen); anti-synaptic vesicle protein 2 (1:30, Developmental 
Hybridoma Bank). 
Cell counting and statistics.We counted all motor neurons and measured gliosis intensities in 
every tenth transverse section of lumbar cord between L3 and L5.  Soma diameters were measured 
by calculating the average length of two lines spanning the diameter of the cell and intersecting like 
crosshairs with the intersection point on the centre of the nucleus.  Data are presented as means ± 
standard error of the means (S.E.M.) as indicated.All results were analyzed to determine the effect of 
SG alone, G37R mutation alone, or the interaction between these two variables by ANOVA via 
Statistica8.0 statistical software (StatSoft Inc., Tulsa, OK).  Statistical significance between groups on 
rotarod performance were analyzed using a repeated measures ANOVA via Statistica8.0 statistical 
software (StatSoft Inc., Tulsa, OK) and graphed usingPrism 5 (GraphPad Software Inc., San Diego, 
CA).  Statistical significance between experimental and control groups for all other behavioural and 
histological assessments were calculated using a Student’s t-test.  The t test was used when only two 
groups and one condition were compared, as in the case of the quantitative histological data.  
Distributions of Nissl stained soma diameters and toluidine blue stained ventral roots were tested 
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for normality using a one-sample Kolmogorov-Smirnov test, and differences between groups for 
each sex and cell morphology were detected using one-way ANOVA.  Following that, a post hoc 
test using multiple comparison Tukey HSD test was used to find out which groups were significantly 
different from controls.  The analysis and graphs of distribution functions were computed by SPSS 
version 17.0 (New York, USA).  Differences were considered statistically significant at p < 0.05.  P 
values were expressed as exact values except in cases where p < 0.0001.  The statistical content and 
methodology was reviewed by a statistician.  
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Figure 1.  Chronic SG exposure in wild type male and female mice provokes a progressive deficit in 
rotarod performance at 30 rpm.(A) SG-fed males showed significant performance deficits by 18 
weeks of age compared with controls (p < 0.0001) and a significant genotype ×diet interaction (p < 
0.005).  (B) SG-fed females showed significant performance deficits by 50 weeks of age (p < 0.05) 
compared with controls, and a significant effect of the G37R genotype was evident (p < 0.0001).  
Data are reported up to 30 weeks of age for male mice and 51 weeks for females.  Note that the 
maximum time was 180 seconds; weeks 4 to 10 represent baseline performance before SG feeding 
in all animals.  Data are expressed as mean ± S.D.  *Significant motor coordination deficits in SG-
fed wild types compared to wild type controls. 
 
Figure 2.  Micrographs of ChAT immunostaining in lumbar spinal sections of control and G37R 
transgenic mice.  (a – d) ChAT-positive cell distribution and number in the lumbar cord of control-
fed wild type (a, b) and SG-fed wild type (c, d) mice.  (e – h) ChAT-positive distribution and number 
in the lumbar cord of control-fed G37R (e, f) and SG-fed G37R (g, h) mice.  In wild type controls, 
motor neurons are widely distributed in the left and right ventral lumbar horn (a) and have a distinct 
nucleus identified with Hoechst staining (b).  In SG-fed wild types, motor neuron loss is noticeable 
from the most ventral portion of the left and right lumbar horns (c) and surviving motor neurons 
also have a distinct nucleus identified with Hoechst staining (d), although overall cell loss was not 
significant in this group for either sex.  The number of ChAT-positive neurons is significantly 
reduced in control-fed (e, f) and SG-fed (g, h) transgenic mice compared with WT controls.  Motor 
neurons in control lumbar cords showed healthy motor neuron morphology and ChAT expression 
(i) while ChAT expression in “ghost cell” (j) and shrunken pyknotic (k) motor neurons were 
observed mostly in transgenic mouse lumbar cords.  Data on graph (l) presented as ratio of motor 
neuron numbers compared to wild type controls ± SD.  When data from both sexes were 
combined, a significant main effect was observed for both diet and genotype.  Scale bars are 300μm 
in the upper micrographs, 60μm in the lower micrographs, and 30 μm in i, j, and k. 
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Figure 3.  Morphological changes in motor neurons in the ventral horn.  Nissl-stained sections 
from the ventrolateral horn of the lumbar cord enlargement of control-fed wild type (a), SG-fed wild 
type (c), control-fed G37R (e) and SG-fed G37R (g) mice.  Neuron density in the ventral horn of the 
transgenic mouse (e, g) was reduced compared with the control (a).  (b – h) are representative higher 
power micrographs of the ventral horn in the corresponding group of the upper panels.  
Morphologically abnormal cells are clearly evident at this magnification, and shrunken (d), 
chromatolytic (f), and ghost cell appearances (h) are observed alongside apparently healthy cells (b), 
although not limited to these corresponding experimental groups.  See text for more details.  Scale 
bars = 60 μm in upper panels, 30 μm in lower panels.   
 
Figure 4.  Changes in cell diameters of different cell morphologies between groups are illustrated by 
a cumulative distribution function.  Data are broken down further into female (a – c) and male (d – 
f) mice.  There was a significant leftward shift of soma diameters of healthy neurons in all 
experimental groups of both female (p < 0.01) and male (p < 0.0001) mice, demonstrating a 
reduction in soma size compared to wild type controls.  A significant reduction in soma size was also 
observed for chromatolytic neurons of SG-fed G37R mice of both sexes (p < 0.05).  Motor neurons 
with pyknotic soma did not show any changes in cell size across groups. 
 
Figure 5.  Micrographs of green fluorescent GFAP immunostaining in lumbar spinal sections of 
control and G37R transgenic mice.  (a, d, g, l) illustrate GFAP-positive cell distribution in the 
lumbar cord of control-fed wild type (a) SG-fed wild type (c), control-fed G37R (g) and SG-fed 
G37R (l) mice.  (b, e, h, m) illustrates GFAP-positive number in the corresponding groups.  (c, f, i, 
n) illustrate representative cell morphologies at high magnification in the corresponding groups.  In 
wild type animals, astroglia are clustered in the left and right ventrolateral lumbar horn (b, e).  In 
G37R mice, astroglial proliferation is uniform throughout the entire grey matter (g, l) and 
significantly increased compared to controls (o).  Astrocyte morphology showed a small cell body 
and long thin processes in control-fed wild type (c) and SG-fed wild type (f) mice.  The control-fed 
G37R mouse either showed activated astrocyte morphology (k) with widespread proliferation (j) or 
cells with increased branching of thin processes (I).  Treatment with SG in mutant animals did not 
change the intensity of astrogliosis (o; compare h – j with m), but all astrocytes had now assumed 
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the activated morphology (n).  Data on graph (o) presented as percent of green fluorescent GFAP 
labelling compared to wild type controls ± S.E.M.  Both sexes showed significant main effects of 
genotype on GFAP proliferation and a significant diet × genotype interaction.  Scale bars are 300μm 
in (a, d, h, l), 60μm in (b, e, h, m), and 30 μm in (c, f, I n). 
 
Figure 6.  Micrographs of red fluorescent Iba1 immunostaining in lumbar spinal sections of control 
and G37R transgenic mice.  (a, d, g, j) illustrate uniform Iba1-positive cell distribution in the lumbar 
cord grey matter of control-fed wild type (a) SG-fed wild type (c), control-fed G37R (g) and SG-fed 
G37R (j) mice.  (b, e, h, k) illustrate Iba1-positive cell numbers in the corresponding groups.  (c, f, i, 
l) illustrate representative cell morphologies at high magnification in the corresponding groups.  
Iba1-positive cells in wild type control lumbar cords (b, c) and SG-fed wild types (e, f) appeared as 
small cell bodies with ramified processes.  The labelling intensity of Iba1 between these two groups 
was comparable (m).  Control-fed G37R mice showed a marked increase in microglia proliferation 
in both sexes (g, m).  Microglia morphology in this group assumed both activated “amoeboid-like” 
morphologies (h) and a transition state with enlarged cell bodies and unretracted processes (i, 
arrow).  Treatment with SG in G37R animals did not change the intensity of microgliosis (m; 
compare h and k), but all microglia were now observed to assume the activated morphology (l).  
Data on graph (m) presented as percent of red fluorescent Iba1 labelling compared to wild type 
controls ± S.E.M.  Both sexes showed significant main effects of genotype on microglia 
proliferation and a significant diet × genotype interaction.  Scale bars are 300μm in (a, d, g, j), 60μm 
in (b, e, h, k), and 30 μm in (c, f, i, l). 
 
Figure 7.  Motor end plates were identified with rhodamine conjugated α-bungarotoxin (red) and 
axons were identified with neurofilament and SV2 (green).  Virtually all motor end plates in wild 
type controls were innervated (a), showing clear overlap between red and green fluorescence 
labelling (b).  Intermediate filaments represented >10% of wild type control mice and approximately 
10% of the other groups, showing an axon in the vicinity of a motor end plate but with no overlap 
(c).  All G37R groups showed significant increases in denervation of motor end plates visualized by 
empty motor end plates (d).  Graph in (e) expressed as mean ± S.D.  Scale bar 40μm.  (** p < 0.001; 
*** p < 0.0001). 
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Figure 8.  All groups showed a similar wide distribution of motor axon diameters (a).  The mean 
axon diameter was 6.4μm for both wild type groups, with SG-fed wild types showing a greater 
number of small diameter axons.  The mean axon diameter was 4.4 and 4.6 μm for SG- and control-
fed G37R groups, respectively.  There was a significant leftward shift of axon diameters in G37R 
groups (p < 0.05), demonstrating a reduction in axon caliber compared to wild type controls (b).  
The steeper initial slope of the histogram corresponding to both G37R groups shows greater 
numbers of motor axons belonging to the smallest diameter range.  Motor axons from SG-fed wild 
types did not show any changes in diameter compared to wild type controls. 
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Figure-1 (Lee)
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